GlassScriptPhysician profile
Stuart A Smalheiser
NPI 1427126663
$45,174.77
in general payments reported to CMS, 2019-2025
17 companies · $23K in 2025
The $23K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,974 · 2020: $372 · 2021: $160 · 2022: $354 · 2023: $474 · 2024: $13K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Food and Beverage: $1,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,000.00 |
| Food and Beverage | $1,315.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shimadzu Precision Instruments, INC. | $35,000.00 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $7,416.18 | 2019-2020 | |
| Abbott Laboratories | $1,626.49 | 2019-2025 | Aveir, Assurity, Jot Dx |
| Cms Imaging, INC. | $560.80 | 2022-2025 | |
| Amgen INC. | $120.99 | 2019-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $97.93 | 2019-2024 | Eliquis |
| Novartis Pharmaceuticals Corporation | $58.23 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.59 | 2024-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $39.49 | 2019 | |
| Biotronik INC. | $35.67 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $35.12 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $35.08 | 2019 | |
| Boston Scientific Corporation | $29.45 | 2019 | |
| Irhythm Technologies, INC. | $16.86 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.33 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $15.42 | 2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Vital Connect, INC | $15.14 | 2023 | Vitalpatch Rtm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Smalheiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.